Cisplatin, fluorouracil, docetaxel in head and neck cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1612, 2007-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Borrmann Type IV Gastric Cancer with a Neoadjuvant Chemotherapy Combination of Docetaxel, Cisplatin and 5-Fluorouracil/Leucovorin

By Sun X-C Lin J Ju A-H

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2096-2102

Field House Publishing

Access to resources Recommend Favorite

Cisplatin/docetaxel/fluorouracil: Muehrcke lines and melanonychia: case report

Reactions Weekly, Vol. 1, Iss. 1261, 2009-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Chemotherapy in head and neck cancer

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Combination therapy with erlotinib and cisplatin is effective in patients with recurrent or metastatic squamous cell cancer of the head and neck

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The antitumour activity of cisplatin-based chemotherapy for head and neck cancer is similar between young and elderly patients

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite